Whites Need Not Apply: Non-White New Yorkers to Receive Priority For Scarce Monoclonal Antibody Treatment

Whites need not apply.

Non-white New Yorkers will receive priority for scarce monoclonal antibody treatments and Covid oral antiviral pills.

The New York State Department of Health this week published a memo warning they don’t have enough Paxlovid or Monoclonal Antibody Treatment so white people will be put at the back of the line.

The NYSDOH said Paxlovid and Molnupiravir are in “limited supply will require providers to prioritize treatment for patients at highest risk for severe COVID-19 until more product becomes available.”

The department said it will be prioritize people who have certain risk factors for severe disease.

One of the risk factors?


“Non-white race or Hispanic/Latino ethnicity should be considered a risk factor, as longstanding systemic health and social inequities have contributed to an increased risk of severe illness and death from Covid-19,” the NYSDOH said.

How is this even legal?

Dear Reader - The enemies of freedom are choking off the Gateway Pundit from the resources we need to bring you the truth. Since many asked for it, we now have a way for you to support The Gateway Pundit directly - and get ad-reduced access. Plus, there are goodies like a special Gateway Pundit coffee mug for supporters at a higher level. You can see all the options by clicking here - thank you for your support!
Photo of author
Cristina began writing for The Gateway Pundit in 2016 and she is now the Associate Editor.

You can email Cristina Laila here, and read more of Cristina Laila's articles here.


Thanks for sharing!